approved EB-2 (NIW)
PhD Student
Biomedical Engineering · Iran · 2025-02-04
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.
Proposed Endeavor
The petitioner proposes to harness stem cell technology and material science to engineer accurate multicellular systems and novel therapies. This work focuses on addressing human organ shortages for transplant, creating better models for drug discovery, and designing advanced delivery systems for cardiovascular disease, chronic kidney disease, and cancer.
Why This Petition Was Approved
The petition was approved based on the petitioner's authorship of 6 peer-reviewed journal articles and a citation record of 719 citations. Additionally, he completed at least 3 peer review assignments and provided 2 expert recommendation letters, satisfying the Dhanasar prongs for merit, national importance, and being well-positioned.
Similar Cases
Scientist
Biotechnology · India
WeGreened EB-2 (NIW) approved
Massachusetts 51 days 2025-09-25
The petitioner proposes to develop, engineer, and refine scalable stem-cell and progenitor-cell-derived organoid systems to revolutionize human organ modeling. Her work focuses on creating miniature, lab-grown structures that replicate complex human tissues for use in drug screening, disease modeling, and patient-specific regenerative therapies.
Researcher
Biotechnology · Taiwan
WeGreened EB-2 (NIW) approved
Maryland 89 days 2022-05-07
The petitioner proposes to continue his research in advancing stem cell and tissue engineering science to develop artificial blood and organs for practical applications in clinical medicine. His work focuses on developing three-dimensional scaffolds for generating liver tissue and gene delivery platforms for directing stem cell differentiation.
Research Scientist
Biotechnology · India
WeGreened EB-2 (NIW) approved
561 days 2025-09-02
The petitioner proposes to continue research in the field of biomedical sciences, specifically exploring molecular blueprints and cell signaling pathways. The work focuses on identifying new drug targets and diagnostic tools for devastating conditions such as Alzheimer’s disease and cancer. This research aims to develop precision therapies that improve public health outcomes through a better understanding of how cellular communication malfunctions.
Scientist
Biotechnology · India
WeGreened EB-2 (NIW) rfe approved
Massachusetts 313 days 2025-02-03
The petitioner proposes to develop state-of-the-art cell and gene therapies to establish cures for debilitating diseases such as cancer and traumatic brain injury. The work focuses on enhancing therapeutic strategies through novel backpack technologies for cell engineering and advanced RNA-based therapeutic platforms.
Frequently Asked Questions
A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.
Browse More Cases
Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-02-04.
Browse all casesAt a Glance
Outcome approved
Processing 166 days
EB-2 (NIW) Case Data
Scraped Case Data
Total Cases 3,895
Success Rate 54.2%
Sustained 2,112
Dismissed 1,687
Related Pages
Get Case Insights
Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.
Join Waitlist